Biocon Launches Rs 4,500 Crore QIP with Floor Price of Rs 340.2 per Share

on Ltd, a BSE 200 pharmaceutical company, announced the opening of its Qualified Institutions Placement (QIP) to raise Rs 4,500 crore. The company set the floor price for the QIP at Rs 340.2 per equity share, as disclosed in an exchange filing. The fundraise follows the Biocon board’s approval in April 2025 to raise capital through various instruments, including shares, non-convertible debt, warrants, or other convertible securities via QIP or rights issue. The Rs 4,500 crore QIP is aimed at bolstering the company’s financial position to support its growth initiatives.